Dr. Donaldson currently serves as the Medical Director for UNC Pulmonary Clinics; Associate Director, UNC Clinical and Translational Research Center and Director, UNC-Chapel Hill Adult CF Care Center. His clinical and research interests are focused on adults with cystic fibrosis (CF). Over the past two decades, he has been involved in the development of several potential new therapies that improve mucus clearance from the lung in CF.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more